Opening the Gates to the Lone Star Agenda

Intro by DM

If a person knowingly inflicted upon hundreds of thousands of people a condition that prevented them from safely consuming a food humans have relied upon for millennia, what would we call that? A mistake? A business model? An experiment? Or something far darker?

Foodocide – The deliberate destruction of a population’s ability to access traditional food.

and

I offer a draft submission to stop this madness:

IN THE UNITED STATES DISTRICT COURT

BETWEEN:

[PLAINTIFF]

and

UNKNOWN PERSONS, ENTITIES, ORGANISATIONS, CONTRACTORS, RESEARCH INSTITUTIONS, FUNDING BODIES, GOVERNMENT AGENCIES, PHILANTHROPIC ORGANISATIONS, COMMERCIAL ENTERPRISES, FOOD-TECHNOLOGY COMPANIES, AND OTHER PARTIES TO BE IDENTIFIED

and

BILL GATES

DEFENDANTS

---

PLAINTIFF’S SUBMISSIONS

INTRODUCTION

1. This proceeding concerns the emergence and expansion of Alpha-gal Syndrome (“AGS”), a recognised medical condition associated with tick exposure and characterised by an acquired allergic reaction to mammalian meat and related products.
2. The Plaintiff contends that substantial questions exist concerning the funding, authorisation, research, development, testing, environmental intervention, deployment, monitoring, regulation, and commercial consequences of activities relating to ticks and tick-borne conditions.
3. The Plaintiff seeks disclosure, discovery, production of documents, and such further orders as may be necessary to identify all persons and entities involved in the matters raised by the evidence.
4. The Plaintiff submits that the issues raised are matters of significant public importance involving public health, bodily integrity, scientific accountability, environmental intervention, and the right of citizens to know the full circumstances surrounding activities that may affect human health.

BACKGROUND

5. Alpha-gal Syndrome is a recognised medical condition associated with exposure to certain tick species.
6. The condition may result in an immune response causing allergic reactions following the consumption of mammalian meat products including beef, pork, lamb, venison and related products.
7. Medical literature has documented a significant increase in reported cases over recent years.
8. Publicly available information suggests that hundreds of thousands of individuals may now be affected.
9. The Plaintiff relies upon the Exhibits annexed to the Affidavit.

NATURE OF THE INJURY

10. The Plaintiff submits that the injuries alleged extend far beyond a mere dietary inconvenience.
11. Alpha-gal Syndrome fundamentally alters the relationship between an individual and food.
12. Persons affected may experience the permanent or long-term loss of the ability to safely consume mammalian meat products that have formed part of the human diet throughout recorded history and prehistory.
13. The injury is not merely economic. It is biological.
14. Affected individuals may be forced to permanently alter their diets, avoid foods safely consumed throughout their lives, and remain in a constant state of vigilance concerning food consumption.
15. The condition carries the risk of severe allergic reactions including anaphylaxis, hospitalisation, airway compromise, cardiovascular distress, and death.
16. The Plaintiff relies upon evidence demonstrating associated symptoms including fatigue, cognitive impairment, gastrointestinal distress, sleep disruption, anxiety, diminished quality of life, and restrictions upon social and family activities.
17. The Plaintiff will contend that the condition constitutes an ongoing interference with bodily integrity, personal autonomy, dietary freedom, lifestyle, health, and wellbeing.

LOSS OF DIETARY FREEDOM

18. The Plaintiff submits that one of the most fundamental aspects of human existence is the ability to obtain nourishment from naturally occurring foods.
19. For countless generations human populations throughout the world have consumed mammalian meat as an important source of nutrition.
20. Mammalian meat remains a significant source of protein, iron, zinc, vitamin B12, amino acids and other nutrients.
21. The Plaintiff will contend that Alpha-gal Syndrome deprives affected persons of the freedom to safely consume foods they have consumed throughout their lives.
22. The resulting injury is not merely nutritional but cultural, social, psychological and biological.
23. The involuntary loss of access to a historically significant human food source is capable of constituting substantial injury and damage.

EVIDENCE OF HARM

24. Reported symptoms include:

(a) severe allergic reactions;

(b) hives and skin eruptions;

(c) itching and swelling;

(d) abdominal pain;

(e) nausea and vomiting;

(f) diarrhoea;

(g) breathing difficulties;

(h) airway swelling;

(i) anaphylaxis;

(j) emergency hospitalisation.

25. Additional reported effects include:

(a) chronic fatigue;

(b) brain fog;

(c) cognitive impairment;

(d) headaches;

(e) sleep disturbance;

(f) joint pain;

(g) anxiety associated with food consumption;

(h) reduced quality of life;

(i) social restrictions;

(j) significant dietary limitations.

26. The Plaintiff submits that these effects are capable of constituting substantial personal injury and ongoing damage.

QUESTIONS REQUIRING DETERMINATION

27. The Plaintiff submits that a number of important questions remain unanswered.
28. These include:

(a) Who funded the relevant programs, projects, research initiatives, studies, grants or activities?

(b) Who designed, authorised or supervised such programs?

(c) Who conducted or implemented such activities?

(d) Were environmental releases, field trials, testing programs or deployment activities undertaken?

(e) What risk assessments, environmental assessments or health impact assessments were prepared?

(f) What knowledge existed concerning potential human health consequences?

(g) What regulatory approvals were sought, granted or denied?

(h) What monitoring occurred following implementation?

(i) What records exist concerning outcomes, consequences, adverse events or unintended effects?

(j) What persons, corporations, investors, organisations or industries may have derived direct or indirect benefit from the resulting circumstances?

POTENTIAL COMMERCIAL BENEFICIARIES

29. The Plaintiff submits that discovery may reveal that certain industries, corporations, investors, research organisations, funding bodies, food-technology companies, pharmaceutical entities, agricultural enterprises or other commercial actors possessed direct or indirect economic interests associated with the expansion of Alpha-gal Syndrome.
30. The Plaintiff does not presently allege wrongdoing by any specific entity.
31. However, the Plaintiff submits that discovery should identify:

(a) entities funding tick-related research;

(b) entities funding alternative protein technologies;

(c) entities funding synthetic meat, cultured meat, precision fermentation or plant-based food technologies;

(d) entities holding patents or intellectual property that may benefit from reductions in traditional meat consumption;

(e) entities engaged in commercial activities connected to the consequences of Alpha-gal Syndrome.

32. The Plaintiff submits that the existence of potential economic beneficiaries is relevant to determining the full factual circumstances surrounding the matters raised in this proceeding.

DISCOVERY REQUIRED

33. The Plaintiff submits that critical information remains unavailable to ordinary members of the public.
34. Relevant records are believed to exist within the possession, custody or control of persons and entities yet to be identified.
35. Without disclosure and discovery, the Plaintiff cannot reasonably determine:

(a) the identity of relevant parties;

(b) the extent of relevant activities;

(c) the existence of funding arrangements;

(d) the relationship between such activities and the harms alleged;

(e) the existence of warnings, risk assessments or internal communications.

PUBLIC INTEREST

36. The matters raised concern public health, environmental integrity, scientific accountability and transparency.
37. Where a condition has affected large numbers of people and continues to expand geographically, there exists a compelling public interest in full disclosure.
38. The Plaintiff does not ask the Court at this stage to determine ultimate liability.
39. The Plaintiff seeks access to evidence necessary to establish the facts.

RELIEF SOUGHT

40. The Plaintiff seeks orders requiring:

(a) preservation of documents;

(b) disclosure of relevant records;

(c) production of grants, contracts, agreements and communications;

(d) production of environmental and health impact assessments;

(e) identification of all persons and entities involved in relevant programs;

(f) production of monitoring data and reports;

(g) such further discovery as the Court considers appropriate;

(h) such further orders as are necessary in the interests of justice.

CONCLUSION

41. The Plaintiff submits that the evidence raises serious and legitimate questions requiring judicial examination.
42. The Plaintiff further submits that disclosure and discovery are necessary to determine the full facts, identify all relevant actors, and establish whether liability exists.
43. Public confidence cannot be maintained through secrecy. Matters affecting the health and wellbeing of large populations demand transparency.
44. The Plaintiff therefore respectfully seeks the relief sought herein.

DATED:

[DATE]

[PLAINTIFF]